Saratoga Health & Biotechnology Portfolio Fund Class A (SHPAX)

Overview

The fund focuses on investing in the healthcare and biotechnology sectors, targeting U.S. and foreign companies without bias towards their market capitalization. It commits at least 80% of its total assets into equity securities, which encapsulates a wide variety of forms including common stocks, preferred stocks, and securities that can be converted into common stocks alongside warrants. A top-down investment strategy is employed, concentrating on harnessing long-term economic trends to guide investment decisions. This approach allows the fund to identify and capitalize on overarching patterns and shifts within the healthcare and biotechnology industries, aiming to secure growth and returns by investing in companies positioned to benefit from these trends.

Products and Services

• Equity Securities of Healthcare and Biotechnology Companies:

  The fund specializes in investing in a broad array of equity securities within the healthcare and biotechnology sectors. This includes stakes in companies of various sizes around the globe, focusing on those that have potential for growth and innovation in medical and biotechnological advancements.

• Common Stocks:

  A primary form of investment, common stocks provide fund holders with a share of ownership in healthcare and biotechnology companies. This allows investors to potentially benefit from dividends and capital appreciation as the companies grow.

• Preferred Stocks and Convertible Securities:

  Offering potentially less risk and volatility than common stocks, preferred stocks and securities convertible into common stocks present alternative opportunities. These financial instruments often come with added benefits, such as fixed dividends and precedence over common stock in the event of liquidation, while also offering the potential for conversion into common stocks under certain conditions.

• Warrants:

  As part of its diverse investment approach, the fund also invests in warrants, which are securities that grant the holder the right, but not the obligation, to buy or sell a company's stock at a specific price before a certain date. Warrants can provide a leveraged return on investment if the stock price moves in the direction anticipated by the fund's advisers.